XML 49 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Business Segment (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Segment Reporting [Abstract]    
Schedule of operations by business segment
   Three Months Ended September 30,   Nine Months Ended September 30, 
   Revenue   Earnings   Revenue   Earnings 
   2022   2021   2022   2021   2022   2021   2022   2021 
FOXO Labs  $7   $23   $(499)  $(1,632)  $71   $67   $(1,952)  $(4,268)
FOXO Life   7    8    (1,157)   (831)   22    26    (3,070)   (1,667)
    14    31    (1,656)   (2,463)   93    93    (5,022)   (5,935)
Corporate and other (a)   -    -    (9,197)   (24,465)   -    -    (40,911)   (30,854)
Interest expense   -    -    (424)   (313)   -    -    (1,250)   (825)
Total  $14   $31   $(11,277)  $(27,241)  $93   $93   $(47,183)  $(37,614)

 

(a)Corporate and other includes equity-based compensation, including the consulting agreement, expense of $2,266 and $42 as well as depreciation expense of $74 and $25 for the three months ended September 30, 2022 and 2021, respectively. Corporate and other includes equity-based compensation, including the consulting agreement, expense of $3,956 and $8 as well as depreciation expense of $159 and $71 for the nine months ended September 30, 2022 and 2021, respectively. The three months ended September 30, 2022 and 2021 included $3,632 and $22,571 for the changes in fair value of convertible debentures, warrant liability, and forward purchase derivative. The nine months ended September 30, 2022 and 2021 also included $28,115 and $24,890 for the changes in fair value of convertible debentures, warrant liability, and forward purchase derivative. See Notes 5, 6, 7, 9 and 11 for additional information.
   Revenue   Earnings 
   2021   2020   2021   2020 
FOXO Labs  $85   $23   $(4,790)  $(1,966)
FOXO Life   35    40    (2,381)   (1,415)
    120    63    (7,171)   (3,381)
Corporate and other(a)             (30,199)   (5,333)
Interest income (expense)             (1,118)   61 
Total  $120   $63   $(38,488)  $(8,653)

 

(a)Corporate and other includes equity-based compensation expense of $131 and $920 as well as depreciation expense of $98 and $1,074 for the years ended December 31, 2021 and 2020, respectively. The year ended December 31, 2021 also includes $21,703 for a non-cash change in fair value of convertible debentures and $400 for an investment impairment. See Notes 3, 4, 6, and 11 for additional information.